Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 255
  • Home
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Alpha-synuclein structure, functions, and interactions

Emamzadeh Fatemeh Nouri

Year : 2016| Volume: 21| Issue : 1 | Page no: 29-29

   This article has been cited by
 
1 a-Synuclein interacts differently with membranes mimicking the inner and outer leaflets of neuronal membranes
Samira Jadavi, Ester Canepa, Alberto Diaspro, Claudio Canale, Annalisa Relini, Silvia Dante
Biochimica et Biophysica Acta (BBA) - Biomembranes. 2022; 1864(1): 183814
[Pubmed]  [Google Scholar] [DOI]
2 Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, a-Synuclein and Neuromelanin in Parkinson’s Disease and Intervention with Turmeric
Zuné Jansen van Rensburg,Shameemah Abrahams,Soraya Bardien,Colin Kenyon
Molecular Neurobiology. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders
Dharmendra Kumar Khatri,Amey Kadbhane,Monica Patel,Shweta Nene,Srividya Atmakuri,Saurabh Srivastava,Shashi Bala Singh
Current Research in Pharmacology and Drug Discovery. 2021; 2: 100022
[Pubmed]  [Google Scholar] [DOI]
4 Modulation of a-synuclein fibrillation by plant metabolites, daidzein, fisetin and scopoletin under physiological conditions
Ankita R. Rane,Harshad Paithankar,Ramakrishna V. Hosur,Sinjan Choudhary
International Journal of Biological Macromolecules. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Molecular insights into a-synuclein interaction with individual human core histones, linker histone, and dsDNA
Sneha Jos,Hemanga Gogoi,Thazhe Kootteri Prasad,Manjunath A. Hurakadli,Neelagandan Kamariah,Balasundaram Padmanabhan,Sivaraman Padavattan
Protein Science. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Prion-like C-Terminal Domain of TDP-43 and a-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils
Shailendra Dhakal,Courtney E. Wyant,Hannah E. George,Sarah E. Morgan,Vijayaraghavan Rangachari
Journal of Molecular Biology. 2021; 433(10): 166953
[Pubmed]  [Google Scholar] [DOI]
7 Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future
Münteha Nur Sonuç Karaboga, SezginturkMustafa Kemal Sezgintürk
Journal of Pharmaceutical and Biomedical Analysis. 2021; : 114479
[Pubmed]  [Google Scholar] [DOI]
8 PARkinsonæs: From cellular mechanisms to potential therapeutics
Zsofia Lengyel-Zhand,Laura N. Puentes,Robert H. Mach
Pharmacology & Therapeutics. 2021; : 107968
[Pubmed]  [Google Scholar] [DOI]
9 Ellagic Acid Modulates Uninduced as well as Mutation and Metal-Induced Aggregation of a-Synuclein: Implications for Parkinson’s Disease
Vinod Kumar Meena,Vijay Kumar,Shivani Karalia,Shivani Garima,Monica Sundd
ACS Chemical Neuroscience. 2021;
[Pubmed]  [Google Scholar] [DOI]
10 Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders
Aaron T. Balana,Matthew R. Pratt
Biochemical Journal. 2021; 478(14): 2733
[Pubmed]  [Google Scholar] [DOI]
11 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
Rachel Underwood,Mary Gannon,Aneesh Pathak,Navya Kapa,Sidhanth Chandra,Alyssa Klop,Talene A. Yacoubian
Acta Neuropathologica Communications. 2021; 9(1)
[Pubmed]  [Google Scholar] [DOI]
12 Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories
Camille Cuveillier,Benoit Boulan,Charlotte Ravanello,Eric Denarier,Jean-Christophe Deloulme,Sylvie Gory-Fauré,Christian Delphin,Christophe Bosc,Isabelle Arnal,Annie Andrieux
Frontiers in Molecular Neuroscience. 2021; 14
[Pubmed]  [Google Scholar] [DOI]
13 Sgt1 Regulates a-Synuclein Subcellular Localization and Expression of Parkinson’s Disease Related Genes, PINK1 and PARK9
Anastasiia Bohush, Agnieszka Góral, Malgorzata Sierant, Barbara Nawrot, Wieslawa Lesniak, Anna Filipek
Biomolecules. 2021; 11(11): 1675
[Pubmed]  [Google Scholar] [DOI]
14 The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies
Samay Prakash, Wayne G. Carter
Brain Sciences. 2021; 11(12): 1573
[Pubmed]  [Google Scholar] [DOI]
15 Interaction between Parkin and a-Synuclein in PARK2-Mediated Parkinson’s Disease
Daniel Aghaie Madsen,Sissel Ida Schmidt,Morten Blaabjerg,Morten Meyer
Cells. 2021; 10(2): 283
[Pubmed]  [Google Scholar] [DOI]
16 MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
Hsiuying Wang
International Journal of Molecular Sciences. 2021; 22(6): 2953
[Pubmed]  [Google Scholar] [DOI]
17 Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson’s Disease in C57BL/6 Mice
Isaac Deng,Frances Corrigan,Sanjay Garg,Xin-Fu Zhou,Larisa Bobrovskaya
International Journal of Molecular Sciences. 2021; 22(14): 7380
[Pubmed]  [Google Scholar] [DOI]
18 Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
Karen M. Delgado-Minjares, Daniel Martinez-Fong, Irma A. Martínez-Dávila, Cecilia Bañuelos, M. E. Gutierrez-Castillo, Víctor Manuel Blanco-Alvarez, Maria-del-Carmen Cardenas-Aguayo, José Luna-Muñoz, Mar Pacheco-Herrero, Luis O. Soto-Rojas
International Journal of Molecular Sciences. 2021; 22(21): 11702
[Pubmed]  [Google Scholar] [DOI]
19 Oxidative stress factors in Parkinson’s disease
Jolanta Dorszewska,Marta Kowalska,Michal Prendecki,Thomas Piekut,Joanna Kozlowska,Wojciech Kozubski
Neural Regeneration Research. 2021; 16(7): 1383
[Pubmed]  [Google Scholar] [DOI]
20 A novel multi-target strategy to attenuate the progression of Parkinsonæs disease by diamine hybrid AGE/ALE inhibitor
N André Sasaki,Pascal Sonnet
Future Medicinal Chemistry. 2021;
[Pubmed]  [Google Scholar] [DOI]
21 Biomarkers of Major Depressive Disorder: Knowing is Half the Battle
Sahil Malik,Ravinder Singh,Govind Arora,Akriti Dangol,Sanjay Goyal
Clinical Psychopharmacology and Neuroscience. 2021; 19(1): 12
[Pubmed]  [Google Scholar] [DOI]
22 Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes
Ching-On Wong
International Journal of Molecular Sciences. 2020; 21(14): 5149
[Pubmed]  [Google Scholar] [DOI]
23 Antibody Fragments as Tools for Elucidating Structure-Toxicity Relationships and for Diagnostic/Therapeutic Targeting of Neurotoxic Amyloid Oligomers
André L. B. Bitencourt,Raquel M. Campos,Erika N. Cline,William L. Klein,Adriano Sebollela
International Journal of Molecular Sciences. 2020; 21(23): 8920
[Pubmed]  [Google Scholar] [DOI]
24 pH-Dependent Aggregation in Intrinsically Disordered Proteins Is Determined by Charge and Lipophilicity
Jaime Santos,Valentín Iglesias,Juan Santos-Suárez,Marco Mangiagalli,Stefania Brocca,Irantzu Pallarès,Salvador Ventura
Cells. 2020; 9(1): 145
[Pubmed]  [Google Scholar] [DOI]
25 From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins
Cristóbal Marrero-Winkens,Charu Sankaran,Hermann M. Schätzl
Biomolecules. 2020; 10(9): 1305
[Pubmed]  [Google Scholar] [DOI]
26 Linking Alpha-Synuclein to the Actin Cytoskeleton: Consequences to Neuronal Function
Marina I. Oliveira da Silva,Márcia A. Liz
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
27 Intracellular Alpha-Synuclein and Immune Cell Function
Veselin Grozdanov,Karin M. Danzer
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
28 Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
Luis D. Bernal-Conde,Rodrigo Ramos-Acevedo,Mario A. Reyes-Hernández,Andrea J. Balbuena-Olvera,Ishbelt D. Morales-Moreno,Rubén Argüero-Sánchez,Birgitt Schüle,Magdalena Guerra-Crespo
Frontiers in Neuroscience. 2020; 13
[Pubmed]  [Google Scholar] [DOI]
29 Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases
Yan Sun,Chuang Guo,Lin Yuan,Wen Li,Zhan-You Wang,Feng Yue,Jia-Yi Li
Frontiers in Neuroscience. 2020; 14
[Pubmed]  [Google Scholar] [DOI]
30 Looking Beyond the Core: The Role of Flanking Regions in the Aggregation of Amyloidogenic Peptides and Proteins
Sabine M. Ulamec,David J. Brockwell,Sheena E. Radford
Frontiers in Neuroscience. 2020; 14
[Pubmed]  [Google Scholar] [DOI]
31 Eye lens crystallin proteins inhibit the autocatalytic amyloid amplification nature of mature a-synuclein fibrils
Ricardo Gaspar,Tommy Garting,Anna Stradner,Peter Schuck
PLOS ONE. 2020; 15(6): e0235198
[Pubmed]  [Google Scholar] [DOI]
32 Identifying the mechanisms of a-synuclein-mediated cytotoxicity in Parkinson’s disease: new insights from a bioinformatics-based approach
Sankha S Chakrabarti,Venkatadri S Sunder,Upinder Kaur,Sapna Bala,Priyanka Sharma,Manjari Kiran,Ravindra K Rawal,Sasanka Chakrabarti
Future Neurology. 2020; : FNL49
[Pubmed]  [Google Scholar] [DOI]
33 Gut-Brain Axis in Parkinsonæs disease Etiology: The Role of Lipopolysaccharide
Dipita Bhattacharyya,Anirban Bhunia
Chemistry and Physics of Lipids. 2020; : 105029
[Pubmed]  [Google Scholar] [DOI]
34 CSF a-synuclein correlates with CSF neurogranin in late-life depression
Davide Bruno,Chelsea Reichert Plaska,Daniel P. A. Clark,Henrik Zetterberg,Kaj Blennow,Marcel M. Verbeek,Nunzio Pomara
International Journal of Neuroscience. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
35 Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson’s disease
Razvan-Marius Brazdis,Julian E Alecu,Daniel Marsch,Annika Dahms,Katrin Simmnacher,Sandra Lörentz,Anna Brendler,Yanni Schneider,Franz Marxreiter,Laurent Roybon,Beate Winner,Wei Xiang,Iryna Prots
Human Molecular Genetics. 2020;
[Pubmed]  [Google Scholar] [DOI]
36 The contribution of Parkin, PINK1 and DJ-1 genes to selective neuronal degeneration in Parkinsonæs disease
Marc van der Vlag,Robbert Havekes,Pim R. A. Heckman
European Journal of Neuroscience. 2020;
[Pubmed]  [Google Scholar] [DOI]
37 The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases
Monika Pichla,Grzegorz Bartosz,Izabela Sadowska-Bartosz,Marco Malaguti
Oxidative Medicine and Cellular Longevity. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
38 Alleviating toxic a-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson’s disease
Alysia Ross,Viktoria Xing,Ting Ting Wang,Samantha C. Bureau,Giovana A. Link,Teresa Fortin,Hui Zhang,Shawn Hayley,Hongyu Sun
Molecular Brain. 2020; 13(1)
[Pubmed]  [Google Scholar] [DOI]
39 Anti-Parkinsonæs disease activity of phenolic acids from Eucommia ulmoides Oliver leaf extracts and their autophagy activation mechanism
Shanshan Zhang,Zhangping Yu,Jingyu Xia,Xuanming Zhang,Kechun Liu,Attila Sik,Meng Jin
Food & Function. 2020;
[Pubmed]  [Google Scholar] [DOI]
40 Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko
RSC Advances. 2020; 10(1): 215
[Pubmed]  [Google Scholar] [DOI]
41 Identification of on- and off-pathway oligomers in amyloid fibril formation
Alexander J. Dear,Georg Meisl,Andela Šaric,Thomas C. T. Michaels,Magnus Kjaergaard,Sara Linse,Tuomas P. J. Knowles
Chemical Science. 2020;
[Pubmed]  [Google Scholar] [DOI]
42 Unravelling the effect of N(e)-(carboxyethyl)lysine on the conformation, dynamics and aggregation propensity of a-synuclein
Laura Mariño,Rafael Ramis,Rodrigo Casasnovas,Joaquín Ortega-Castro,Bartolomé Vilanova,Juan Frau,Miquel Adrover
Chemical Science. 2020; 11(12): 3332
[Pubmed]  [Google Scholar] [DOI]
43 Unraveling the NaCl Concentration Effect on the First Stages of a-Synuclein Aggregation
Rafael Ramis,Joaquín Ortega-Castro,Bartolomé Vilanova,Miquel Adrover,Juan Frau
Biomacromolecules. 2020;
[Pubmed]  [Google Scholar] [DOI]
44 Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease
David J. Marmion,Angela A. Rutkowski,Diptaman Chatterjee,Benjamin M. Hiller,Milton H. Werner,Erwan Bezard,Deniz Kirik,Thomas McCown,Steven J. Gray,Jeffrey H. Kordower
Neurobiology of Disease. 2020; : 105184
[Pubmed]  [Google Scholar] [DOI]
45 Remodeling microglia to a protective phenotype in Parkinson’s disease?
Ifeoluwa Oluleke Awogbindin,Ismail Ogunbayode Ishola,Marie-Kim St-Pierre,Micaël Carrier,Julie C. Savage,Thérèse Di Paolo,Marie-Ève Tremblay
Neuroscience Letters. 2020; : 135164
[Pubmed]  [Google Scholar] [DOI]
46 Genetics of synucleins in neurodegenerative diseases
José Brás,Elizabeth Gibbons,Rita Guerreiro
Acta Neuropathologica. 2020;
[Pubmed]  [Google Scholar] [DOI]
47 6-Hydroxydopamine: a far from simple neurotoxin
Damir Varešlija,Keith F. Tipton,Gavin P. Davey,Andrew G. McDonald
Journal of Neural Transmission. 2020;
[Pubmed]  [Google Scholar] [DOI]
48 Using NMR spectroscopy to investigate the role played by copper in prion diseases
Rawiah A. Alsiary,Mawadda Alghrably,Abdelhamid Saoudi,Suliman Al-Ghamdi,Lukasz Jaremko,Mariusz Jaremko,Abdul-Hamid Emwas
Neurological Sciences. 2020;
[Pubmed]  [Google Scholar] [DOI]
49 Overexpression of a-Synuclein Reorganises Growth Factor Profile of Human Astrocytes
Büsra Sengül,Erdinç Dursun,Alexei Verkhratsky,Duygu Gezen-Ak
Molecular Neurobiology. 2020;
[Pubmed]  [Google Scholar] [DOI]
50 Mitochondrial Protein Import Dysfunction in Pathogenesis of Neurodegenerative Diseases
Shweta Goyal,Rajnish Kumar Chaturvedi
Molecular Neurobiology. 2020;
[Pubmed]  [Google Scholar] [DOI]
51 Lipopolysaccharide Animal Models of Parkinson’s Disease: Recent Progress and Relevance to Clinical Disease
Isaac Deng,Frances Corrigan,Guangxi Zhai,Xin-Fu Zhou,Larisa Bobrovskaya
Brain, Behavior, & Immunity - Health. 2020; : 100060
[Pubmed]  [Google Scholar] [DOI]
52 Prion Efficiently Replicates in a-Synuclein Knockout Mice
Edoardo Bistaffa,Martina Rossi,Chiara Maria Giulia De Luca,Federico Cazzaniga,Olga Carletta,Ilaria Campagnani,Fabrizio Tagliavini,Giuseppe Legname,Giorgio Giaccone,Fabio Moda
Molecular Neurobiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
53 Reprint of “Ganglioside lipids accelerate a-synuclein amyloid formation”
Ricardo Gaspar,Jon Pallbo,Ulrich Weininger,Sara Linse,Emma Sparr
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2019;
[Pubmed]  [Google Scholar] [DOI]
54 Alpha synuclein in hematopoiesis and immunity
Yu Pei,Robert W. Maitta
Heliyon. 2019; 5(10): e02590
[Pubmed]  [Google Scholar] [DOI]
55 The Role of Aptamer Loaded Exosome Complexes in the Neurodegenerative Diseases
Simranjeet Singh Sekhon,Gna Ahn,Ga-Young Park,Dae-Young Park,Sang-Hee Lee,Ji-Young Ahn,Yang-Hoon Kim
Toxicology and Environmental Health Sciences. 2019; 11(2): 85
[Pubmed]  [Google Scholar] [DOI]
56 In-vitro and in-silico investigation of protective mechanisms of crocin against E46K a-synuclein amyloid formation
Marzieh Ghasemi Tigan,Arezou Ghahghaei,Milad Lagzian
Molecular Biology Reports. 2019;
[Pubmed]  [Google Scholar] [DOI]
57 Selective vulnerability in a-synucleinopathies
Javier Alegre-Abarrategui,Katherine R. Brimblecombe,Rosalind F. Roberts,Elisavet Velentza-Almpani,Bension S. Tilley,Nora Bengoa-Vergniory,Christos Proukakis
Acta Neuropathologica. 2019;
[Pubmed]  [Google Scholar] [DOI]
58 Plasma a -synuclein levels are increased in patients with obstructive sleep apnea syndrome
Hao-Lun Sun,Bin-Lu Sun,Dong-Wan Chen,Yang Chen,Wei-Wei Li,Man-Yu Xu,Ying-Ying Shen,Zhi-Qiang Xu,Yan-Jiang Wang,Xian-Le Bu
Annals of Clinical and Translational Neurology. 2019;
[Pubmed]  [Google Scholar] [DOI]
59 A Coarse-Grained Molecular Dynamics Approach to the Study of the Intrinsically Disordered Protein a-Synuclein
Rafael Ramis,Joaquín Ortega-Castro,Rodrigo Casasnovas,Laura Mariño,Bartolomé Vilanova,Miquel Adrover,Juan Frau
Journal of Chemical Information and Modeling. 2019; 59(4): 1458
[Pubmed]  [Google Scholar] [DOI]
60 Mass Spectrometric Analysis of Lewy Body-Enriched a-Synuclein in Parkinson’s Disease
Payel Bhattacharjee,Annika Öhrfelt,Tammaryn Lashley,Kaj Blennow,Ann Brinkmalm,Henrik Zetterberg
Journal of Proteome Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
61 Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Nashwa Amin,Xiaoning Tan,Qiannan Ren,Ning Zhu,Benson O.A. Botchway,Zhiying Hu,Marong Fang
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019; 95: 109674
[Pubmed]  [Google Scholar] [DOI]
62 a-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinsonæs disease patients
Wojciech Paslawski,Justyna Zareba-Paslawska,Xiaoqun Zhang,Katharina Hölzl,Henrik Wadensten,Mohammadreza Shariatgorji,Shorena Janelidze,Oskar Hansson,Lars Forsgren,Per E. Andrén,Per Svenningsson
Proceedings of the National Academy of Sciences. 2019; : 201821409
[Pubmed]  [Google Scholar] [DOI]
63 Deciphering the anti-Parkinson’s activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the a-Synuclein mutants A30P, A53T, E46K, E57K and E35K
Gitanjali P Panigrahi,Ankita R Rane,Sirisha L Vavilala,Sinjan Choudhary
The Journal of Biochemistry. 2019;
[Pubmed]  [Google Scholar] [DOI]
64 Upcoming diagnostic biomarkers with promising prospects in neurological disorders
Wasim Ahmad,Abuzer Ali,Amena Ali,Sana Khan,Saba Khan,Ibraheem Husain
Clinical and Experimental Pharmacology and Physiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
65 Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides
Guru KrishnaKumar Viswanathan,Ashim Paul,Ehud Gazit,Daniel Segal
Frontiers in Cell and Developmental Biology. 2019; 7
[Pubmed]  [Google Scholar] [DOI]
66 Physiological, molecular and genetic aspects of alpha-synuclein and its correlation with high alcohol consumption
Tania Yadira Martínez-Rodríguez,Mauricio Rey-Buitrago
Revista de la Facultad de Medicina. 2019; 67(3): 315
[Pubmed]  [Google Scholar] [DOI]
67 Early stages of Parkinson’s disease: aspects of the diagnosis and therapy
A. A. Pilipovich
Medical Council. 2019; (18): 61
[Pubmed]  [Google Scholar] [DOI]
68 Lipids at the Crossroad of a-Synuclein Function and Dysfunction: Biological and Pathological Implications
Natalia P. Alza,Pablo A. Iglesias González,Melisa A. Conde,Romina M. Uranga,Gabriela A. Salvador
Frontiers in Cellular Neuroscience. 2019; 13
[Pubmed]  [Google Scholar] [DOI]
69 Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Maria Zella,Judith Metzdorf,Friederike Ostendorf,Fabian Maass,Siegfried Muhlack,Ralf Gold,Aiden Haghikia,Lars Tönges
Cells. 2019; 8(2): 105
[Pubmed]  [Google Scholar] [DOI]
70 Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
Carlo Scialò,Elena De Cecco,Paolo Manganotti,Giuseppe Legname
Viruses. 2019; 11(3): 261
[Pubmed]  [Google Scholar] [DOI]
71 Mechanical and thermodynamic properties of Aß42, Aß40, and a-synuclein fibrils: a coarse-grained method to complement experimental studies
Adolfo B Poma,Horacio V Guzman,Mai Suan Li,Panagiotis E Theodorakis
Beilstein Journal of Nanotechnology. 2019; 10: 500
[Pubmed]  [Google Scholar] [DOI]
72 Implications of alpha-synuclein nitration at tyrosine 39 in methamphetamine-induced neurotoxicity in vitro and in vivo
Hong-Hua Qiao,Lin-Nan Zhu,Yue Wang,Jia-Liang Hui,Wei-Bing Xie,Chao Liu,Ling Chen,Ping-Ming Qiu
Neural Regeneration Research. 2019; 14(2): 319
[Pubmed]  [Google Scholar] [DOI]
73 Comparing the Folds of Prions and Other Pathogenic Amyloids
José Flores-Fernández,Vineet Rathod,Holger Wille
Pathogens. 2018; 7(2): 50
[Pubmed]  [Google Scholar] [DOI]
74 Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology
Orkid Coskuner-Weber,Vladimir Uversky
International Journal of Molecular Sciences. 2018; 19(2): 336
[Pubmed]  [Google Scholar] [DOI]
75 Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease
Manuel Menéndez-González,Huber Padilla-Zambrano,Cristina Tomás-Zapico,Benjamin García
Brain Sciences. 2018; 8(4): 52
[Pubmed]  [Google Scholar] [DOI]
76 Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Fatemeh N. Emamzadeh,Andrei Surguchov
Frontiers in Neuroscience. 2018; 12
[Pubmed]  [Google Scholar] [DOI]
77 Effect of rs3910105 in the Synuclein Gene on Dopamine Transporter Availability in Healthy Subjects
Youngduk Seo,Kyoungjune Pak,Hyun-Yeol Nam,Ju Won Seok,Myung Jun Lee,Eun-Joo Kim,Jae Meen Lee,Seong Jang Kim,In Joo Kim
Yonsei Medical Journal. 2018; 59(6): 787
[Pubmed]  [Google Scholar] [DOI]
78 Crucial role of protein oligomerization in the pathogenesis of Alzheimeræs and Parkinsonæs diseases
Minee L. Choi,Sonia Gandhi
The FEBS Journal. 2018;
[Pubmed]  [Google Scholar] [DOI]
79 The Cellular Environment Affects Monomeric a-Synuclein Structure
Amberley D. Stephens,Maria Zacharopoulou,Gabriele S. Kaminski Schierle
Trends in Biochemical Sciences. 2018;
[Pubmed]  [Google Scholar] [DOI]
80 Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum
Thaiany Quevedo Melo,Sjef J. C. V. M. Copray,Merari F. R. Ferrari
Neurochemical Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
81 Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
S. L. Sison,S. C. Vermilyea,M. E. Emborg,A. D. Ebert
Current Neurology and Neuroscience Reports. 2018; 18(12)
[Pubmed]  [Google Scholar] [DOI]
82 Formation of Heterotypic Amyloids: a-Synuclein in Co-Aggregation
Karishma Bhasne,Samrat Mukhopadhyay
PROTEOMICS. 2018; : 1800059
[Pubmed]  [Google Scholar] [DOI]
83 Cellular Proteostasis in Neurodegeneration
Alberim Kurtishi,Benjamin Rosen,Ketan S. Patil,Guido W. Alves,Simon G. Møller
Molecular Neurobiology. 2018;
[Pubmed]  [Google Scholar] [DOI]
84 Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment
Jimena H. Martínez,Federico Fuentes,Virginia Vanasco,Silvia Alvarez,Agustina Alaimo,Adriana Cassina,Federico Coluccio Leskow,Francisco Velazquez
Archives of Biochemistry and Biophysics. 2018; 651: 1
[Pubmed]  [Google Scholar] [DOI]
85 Post-translational modifications of Parkinsonæs disease-related proteins: Phosphorylation, SUMOylation and ubiquitination
Stella C. Junqueira,Eduarda G.Z. Centeno,Kevin A. Wilkinson,Helena Cimarosti
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;
[Pubmed]  [Google Scholar] [DOI]
86 The role of posttranslational modifications of a-synuclein and LRRK2 in Parkinsonæs disease: Potential contributions of environmental factors
Edward Pajarillo,Asha Rizor,Jayden Lee,Michael Aschner,Eunsook Lee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;
[Pubmed]  [Google Scholar] [DOI]
87 Salt-bridge dynamics in intrinsically disordered proteins: A trade-off between electrostatic interactions and structural flexibility
Sankar Basu,Parbati Biswas
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2018; 1866(5-6): 624
[Pubmed]  [Google Scholar] [DOI]
88 Ganglioside lipids accelerate a-synuclein amyloid formation
Ricardo Gaspar,Jon Pallbo,Ulrich Weininger,Sara Linse,Emma Sparr
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2018; 1866(10): 1062
[Pubmed]  [Google Scholar] [DOI]
89 Recent progress of drug nanoformulations targeting to brain
Abdur Rauf Khan,Xiaoye Yang,Manfei Fu,Guangxi Zhai
Journal of Controlled Release. 2018;
[Pubmed]  [Google Scholar] [DOI]
90 Small molecule probes of protein aggregation
Lydia M Young,Alison E Ashcroft,Sheena E Radford
Current Opinion in Chemical Biology. 2017; 39: 90
[Pubmed]  [Google Scholar] [DOI]
91 DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers
Patricia S. Muñoz,Juan Segura-Aguilar
Neurotoxicity Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
92 Role of Apolipoproteins and a-Synuclein in Parkinson’s Disease
Fatemeh Nouri Emamzadeh
Journal of Molecular Neuroscience. 2017;
[Pubmed]  [Google Scholar] [DOI]
93 Bone loss in C57BL/6J-OlaHsd mice, a substrain of C57BL/6J carrying mutated alpha-synuclein and multimerin-1 genes
Tamar Liron,Bitya Raphael,Sahar Hiram-Bab,Itai A. Bab,Yankel Gabet
Journal of Cellular Physiology. 2017;
[Pubmed]  [Google Scholar] [DOI]
94 Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells
Wenbo Yu,Sheng Chen,Liang Cao,Jie Tang,Wei Xiao,Baoguo Xiao
Cell Biology and Toxicology. 2017;
[Pubmed]  [Google Scholar] [DOI]
95 iPS cells in the study of PD molecular pathogenesis
Melanie M. Cobb,Abinaya Ravisankar,Gaia Skibinski,Steven Finkbeiner
Cell and Tissue Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
96 Up-regulation of autophagy-related gene 5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinsonæs disease
Zhan-ying Hu,Bo Chen,Jing-pu Zhang,Yuan-yuan Ma
Journal of Biological Chemistry. 2017; 292(44): 18062
[Pubmed]  [Google Scholar] [DOI]
97 Familial Mutations May Switch Conformational Preferences in a-Synuclein Fibrils
Liang Xu,Buyong Ma,Ruth Nussinov,Damien Thompson
ACS Chemical Neuroscience. 2017;
[Pubmed]  [Google Scholar] [DOI]
98 Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects
Kyoungjune Pak,Seunghyeon Shin,So Jung Kim,Keunyoung Kim,Bum Soo Kim,Seong Jang Kim,In Joo Kim
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
99 Finding a new purpose for old drugs
Evan Y. Snyder
Science. 2017; 357(6354): 869
[Pubmed]  [Google Scholar] [DOI]
100 Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?
Alexei A. Surguchev,Andrei Surguchov
Frontiers in Molecular Neuroscience. 2017; 10
[Pubmed]  [Google Scholar] [DOI]
101 a-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinsonæs disease
Sushil K Singh,Aloke Dutta,Gyan Modi
Future Medicinal Chemistry. 2017; 9(10): 1039
[Pubmed]  [Google Scholar] [DOI]

 

Read this article